The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Pluvicto in the real world setting and timing to PSA50 as a predictive marker of treatment response.

Diana Vesselinovitch  Maslov

No Relationships to Disclose

Jacob  New

No Relationships to Disclose

Nikunj  Patel

No Relationships to Disclose

Michael P.  Kosty

Honoraria - Mirati Therapeutics; Myovnt; Philips Respironics

Consulting or Advisory Role - Myovant Sciences

Speakers' Bureau - Mirati Therapeutics

Research Funding - Amgen (Inst); AstraZeneca (Inst); E.R. Squibb  Sons, LLC (Inst); Genentech/Roche (Inst); Merch Sharp Dhome (Inst); Merck Serono (Inst); Roche (Inst)

Munveer Singh  Bhangoo

Consulting or Advisory Role - Foundation Medicine; Foundation Medicine

Speakers' Bureau - Bristol-Myers Squibb; Exelixis